Efficacy of Restricted Use of Sirolimus-eluting Stents in "Real Life"

Author	: Philipp Schweizer
Publisher	:
Total Pages	: 42
Release	: 2013
ISBN-10	: OCLC:868129317
ISBN-13	:
Rating	: 4/5 ( Downloads)

DOWNLOAD EBOOK

Book Synopsis Efficacy of Restricted Use of Sirolimus-eluting Stents in "Real Life" by : Philipp Schweizer

Download or read book Efficacy of Restricted Use of Sirolimus-eluting Stents in "Real Life" written by Philipp Schweizer and published by . This book was released on 2013 with total page 42 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Efficacy of Restricted Use of Sirolimus-eluting Stents in "Real Life" Related Books

Language: en
Pages: 42

Efficacy of Restricted Use of Sirolimus-eluting Stents in "Real Life"

Authors: Philipp Schweizer

Categories:

Type: BOOK - Published: 2013 - Publisher:

DOWNLOAD EBOOK

Language: en
Pages: 316

The Unrestricted Use of Paclitaxel-eluting Stents and Eirolimus-eluting Stents in the Rotterdam T-SEARCH and RESEARCH Registries: Studies on Efficacy, Safety, Stent Thrombosis, Cost Eff Ectiveness and the Future

Authors: Andrew Teck Leong Ong

Categories:

Type: BOOK - Published: 2007 - Publisher:

DOWNLOAD EBOOK

Language: en
Pages: 234

Drug-Coated Balloons

Authors: Bernardo Cortese

Categories: Medical

Type: BOOK - Published: 2019-06-19 - Publisher: Springer

DOWNLOAD EBOOK

This book provides a comprehensive, up-to-date summary of drug-coated balloon (DCB) technology and the role of DCBs in the treatment of coronary and peripheral

Language: en
Pages: 210

Sirolimus-Eluting Stents

Authors: Patrick W. Serruys

Categories: Medical

Type: BOOK - Published: 2004-11-29 - Publisher: CRC Press

DOWNLOAD EBOOK

Recently, sirolimus-eluting stents implantation has been shown to decrease restenosis markedly in selected patients. Nonetheless, the effects of SES implantatio

Language: en
Pages: 533

Bioresorbable Scaffolds

Authors: Yoshinobu Onuma

Categories: Medical

Type: BOOK - Published: 2017-10-02 - Publisher: CRC Press

DOWNLOAD EBOOK

This book focuses on the coronary bioresorbable scaffold, a new interventional treatment for coronary artery disease, differentiated from a permanent metallic s